Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious stages of ...

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression ...

The final stages of Alzheimer’s disease represent one of the most challenging periods for families watching their loved ones navigate this devastating condition. Understanding the critical signs that ...

Diagnosing Alzheimer's disease and determining a patient's prognosis is an inexact business, and that stands in the way of better personalized care and advances in treatment. A new study from The Ohio ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

Most individuals are currently diagnosed with Alzheimer’s disease only after cognitive decline has set in and brain damage has become irreversible. Alterations in brain metabolism and blood flow to ...

Older Americans want to know if they are in the early stages of Alzheimer's disease and would happily take a blood test to find out, according to a national survey. The survey of 1,700 people 45 and ...

Microglia are known to play an important role in Alzheimer's disease, but exactly what they do has remained a mystery. Scientists in the Bart De Strooper Lab at the VIB-KU Leuven Center for Brain & ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...